A forum for researchers, students and applicants in the field of cyclodextrin technology
This study successfully demonstrates the preparation of a vitamin D3:SBE-BCD inclusion complex using an eco-friendly, microwave-assisted method that minimizes solvent
This review outlines the structural features of native CDs and their chemically modified derivatives, emphasizing the influence of functionalization on
Clinical trial NCT07079761 may help us understand treatable factors that increase risk for chronic or treatment-resistant Post Traumatic Stress Disorder
Topical statin therapy holds promise for ocular diseases, such as age-related macular degeneration, but the effective delivery to the posterior
Two hydrophobic (deep) eutectic solvents (H(D)ESs), menthol:octanoic acid (Men:OctA) and menthol:trioctylphosphine oxide (Men:TOPO), were prepared, characterized, and then employed for
Ulcerative colitis (UC), a major subtype of inflammatory bowel disease (IBD) alongside Crohn’s disease, is characterized by a relapsing and
The nociceptive Transient Receptor Potential Vanilloid 1 (TRPV1) and Ankyrin 1 (TRPA1) channels are predominantly expressed on peptidergic sensory nerves,
This review explores the latest innovations in CD-based drug delivery, emphasizing their impact on both cancer treatment and antimicrobial strategies.
The bioavailability of a drug depends, among other parameters, on solubility. One of the strategies used to enhance the solubility
Modified cyclodextrins (CDs) are cyclic oligosaccharides with many applications in drug delivery, catalysis, and as active pharmaceutical ingredients. In general,
